Navigation Links
Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event "Sequenom: The Future of Noninvasive Prenatal Diagnostics." Details of the event are as follows:

What: Sequenom: The Future of Noninvasive Prenatal Diagnostics

When: Tuesday, June 3, 2008 at 6:00 p.m. Pacific time



Hosted by:

Harry Stylli, Ph.D., Chief Executive Officer of Sequenom, Inc.


Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine

Brown University Medical School

"Methods for screening pregnancies for Down syndrome"

Allan T. Bombard, MD, FACOG, FACS, FACMG, Chief Medical Officer, Sharp

Mary Birch Hospital; Adjunct Professor, Obstetrics and Gynecology/SUNY

Downstate Medical Center; Clinical Professor, Albert Einstein College of


"Current clinical practice for Down syndrome screening and diagnosis"

Betty Dragon, Ph.D., Senior Vice President, Research & Development of

Sequenom, Inc.

"Sequenom's SEQureDx: A noninvasive prenatal diagnostic test for Down

syndrome. Technical Achievements, Milestones and Future Challenges"

Dennis Lo, Consultant to Sequenom, Inc.

"The future of prenatal diagnosis: Progress through fetal nucleic acids"

How: Live over the Internet - Simply log on to the web at the address

above. Presentation will be archived.

Contact: Lippert/Heilshorn & Associates

Jody Cain (


About Sequenom

Sequenom is committed to providing the best genetic analysis products for research and the molecular diagnostic markets. The Company makes available superior solutions for genomic science in biomedical research, livestock and agricultural applications and molecular medicine, as well as for various diagnostic markets, including noninvasive prenatal testing, oncology and infectious diseases. Sequenom's proprietary MassARRAY(R) system delivers reliable and specific data from complex biological samples and from genetic target materials available only in trace amounts.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an E-mail to:

SOURCE Sequenom, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
2. REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO
3. Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing
4. CorVel Corporation Announces Earnings Release Webcast
5. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
6. Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
8. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
9. Quest Diagnostics Announces Annual Shareholders Meeting Webcast
10. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
11. Exelixis Announces May 13 Webcast of Presentation at the Bank of America Health Care Conference
Post Your Comments:
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
Breaking Biology Technology:
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/12/2016)... , May 12, 2016 , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):